| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelium, Vascular | 9 | 2011 | 468 | 1.070 |
Why?
|
| Thioredoxins | 3 | 2010 | 28 | 0.900 |
Why?
|
| Nitric Oxide Synthase Type III | 8 | 2008 | 186 | 0.790 |
Why?
|
| Reactive Oxygen Species | 3 | 2010 | 521 | 0.730 |
Why?
|
| Aortic Aneurysm, Thoracic | 8 | 2013 | 699 | 0.690 |
Why?
|
| Up-Regulation | 9 | 2011 | 825 | 0.670 |
Why?
|
| Aortic Aneurysm | 2 | 2021 | 225 | 0.650 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 5 | 2010 | 125 | 0.640 |
Why?
|
| Forkhead Transcription Factors | 4 | 2012 | 371 | 0.630 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2006 | 252 | 0.630 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2012 | 480 | 0.560 |
Why?
|
| Palmitic Acid | 4 | 2010 | 27 | 0.520 |
Why?
|
| RNA, Small Interfering | 7 | 2010 | 664 | 0.500 |
Why?
|
| Cells, Cultured | 15 | 2012 | 2885 | 0.470 |
Why?
|
| Muscle, Smooth, Vascular | 6 | 2013 | 223 | 0.450 |
Why?
|
| Activating Transcription Factor 2 | 3 | 2010 | 16 | 0.430 |
Why?
|
| Endothelial Cells | 6 | 2010 | 523 | 0.430 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 3 | 2013 | 94 | 0.380 |
Why?
|
| Pulmonary Medicine | 1 | 2013 | 33 | 0.380 |
Why?
|
| Gene Expression Regulation | 4 | 2010 | 2323 | 0.350 |
Why?
|
| Histone Deacetylases | 2 | 2010 | 130 | 0.340 |
Why?
|
| Insulin | 2 | 2006 | 1149 | 0.330 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 227 | 0.320 |
Why?
|
| Thrombomodulin | 1 | 2010 | 18 | 0.310 |
Why?
|
| MAP Kinase Signaling System | 3 | 2006 | 300 | 0.310 |
Why?
|
| Lung Diseases | 1 | 2013 | 398 | 0.290 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2009 | 170 | 0.270 |
Why?
|
| Metformin | 1 | 2010 | 174 | 0.270 |
Why?
|
| Cytomegalovirus | 2 | 2006 | 259 | 0.260 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2021 | 171 | 0.260 |
Why?
|
| Venous Thromboembolism | 1 | 2010 | 195 | 0.250 |
Why?
|
| Gene Expression Regulation, Enzymologic | 5 | 2008 | 242 | 0.250 |
Why?
|
| Fatty Acids | 1 | 2009 | 377 | 0.250 |
Why?
|
| Forkhead Box Protein O1 | 3 | 2012 | 99 | 0.240 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2006 | 112 | 0.240 |
Why?
|
| Aorta, Thoracic | 6 | 2013 | 530 | 0.240 |
Why?
|
| Resistin | 1 | 2006 | 30 | 0.230 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 480 | 0.230 |
Why?
|
| Repressor Proteins | 1 | 2010 | 760 | 0.230 |
Why?
|
| Cell Differentiation | 2 | 2013 | 1928 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 6 | 2012 | 1207 | 0.220 |
Why?
|
| Apoptosis | 4 | 2021 | 1827 | 0.210 |
Why?
|
| Glucose | 1 | 2009 | 853 | 0.210 |
Why?
|
| Carrier Proteins | 1 | 2009 | 993 | 0.200 |
Why?
|
| Cytomegalovirus Infections | 1 | 2005 | 223 | 0.200 |
Why?
|
| Procollagen-Proline Dioxygenase | 3 | 2008 | 31 | 0.190 |
Why?
|
| Angiotensin II | 2 | 2013 | 131 | 0.180 |
Why?
|
| Blotting, Western | 4 | 2010 | 1013 | 0.180 |
Why?
|
| China | 2 | 2013 | 278 | 0.170 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2010 | 223 | 0.160 |
Why?
|
| Signal Transduction | 5 | 2013 | 4686 | 0.160 |
Why?
|
| Aorta | 6 | 2013 | 521 | 0.160 |
Why?
|
| RNA, Messenger | 8 | 2013 | 2550 | 0.150 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2012 | 135 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 410 | 0.140 |
Why?
|
| Humans | 28 | 2021 | 131163 | 0.140 |
Why?
|
| Case-Control Studies | 4 | 2012 | 3359 | 0.130 |
Why?
|
| Phosphorylation | 3 | 2012 | 1571 | 0.130 |
Why?
|
| Protein Binding | 2 | 2012 | 1652 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 1205 | 0.120 |
Why?
|
| Enzyme Activation | 3 | 2006 | 576 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2008 | 639 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2012 | 3819 | 0.110 |
Why?
|
| RNA | 2 | 2008 | 517 | 0.110 |
Why?
|
| Introns | 4 | 2008 | 278 | 0.110 |
Why?
|
| Chemistry, Clinical | 1 | 2014 | 10 | 0.100 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2014 | 38 | 0.100 |
Why?
|
| Aortitis | 1 | 2012 | 6 | 0.100 |
Why?
|
| Elastic Tissue | 1 | 2012 | 17 | 0.100 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2012 | 10 | 0.100 |
Why?
|
| PPAR gamma | 1 | 2013 | 88 | 0.090 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2012 | 38 | 0.090 |
Why?
|
| Enzyme Induction | 1 | 2012 | 92 | 0.090 |
Why?
|
| Transcription Factor AP-1 | 1 | 2013 | 110 | 0.090 |
Why?
|
| Thiazolidinediones | 1 | 2013 | 81 | 0.090 |
Why?
|
| ADAM Proteins | 1 | 2012 | 78 | 0.090 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 2085 | 0.090 |
Why?
|
| Receptor, Notch1 | 1 | 2012 | 78 | 0.090 |
Why?
|
| Apolipoproteins E | 2 | 2011 | 187 | 0.090 |
Why?
|
| Fibroblasts | 2 | 2013 | 849 | 0.090 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 63 | 0.090 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2012 | 38 | 0.090 |
Why?
|
| Forecasting | 1 | 2013 | 351 | 0.090 |
Why?
|
| Cadmium | 1 | 2011 | 33 | 0.090 |
Why?
|
| Collagen Type III | 2 | 2013 | 23 | 0.090 |
Why?
|
| Vasculitis | 1 | 2011 | 47 | 0.080 |
Why?
|
| DNA Primers | 2 | 2009 | 599 | 0.080 |
Why?
|
| Atherosclerosis | 2 | 2011 | 948 | 0.080 |
Why?
|
| Public Health | 1 | 2013 | 269 | 0.080 |
Why?
|
| Collagen Type I | 2 | 2013 | 110 | 0.080 |
Why?
|
| Plasmids | 2 | 2009 | 449 | 0.080 |
Why?
|
| Reference Values | 1 | 2012 | 676 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 359 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2012 | 928 | 0.080 |
Why?
|
| PPAR alpha | 1 | 2010 | 54 | 0.080 |
Why?
|
| Fenofibrate | 1 | 2010 | 59 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 88 | 0.080 |
Why?
|
| Aged | 7 | 2014 | 21025 | 0.080 |
Why?
|
| Transfection | 3 | 2006 | 962 | 0.080 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2009 | 18 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 288 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 189 | 0.070 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2009 | 31 | 0.070 |
Why?
|
| Ribonucleotides | 1 | 2009 | 31 | 0.070 |
Why?
|
| Middle Aged | 8 | 2014 | 28601 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2010 | 312 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1591 | 0.070 |
Why?
|
| Octamer Transcription Factors | 1 | 2008 | 9 | 0.070 |
Why?
|
| Gene Silencing | 2 | 2006 | 229 | 0.070 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2008 | 18 | 0.070 |
Why?
|
| Myocardium | 1 | 2013 | 852 | 0.070 |
Why?
|
| Nucleotides | 1 | 2008 | 88 | 0.070 |
Why?
|
| Histones | 2 | 2008 | 541 | 0.070 |
Why?
|
| Antioxidants | 1 | 2010 | 331 | 0.070 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 1 | 2007 | 7 | 0.060 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2007 | 12 | 0.060 |
Why?
|
| Disease Progression | 1 | 2013 | 2200 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1447 | 0.060 |
Why?
|
| Linoleic Acid | 1 | 2006 | 20 | 0.060 |
Why?
|
| Binding Sites | 2 | 2006 | 1133 | 0.060 |
Why?
|
| Immediate-Early Proteins | 1 | 2006 | 57 | 0.060 |
Why?
|
| Oncogene Protein v-akt | 1 | 2005 | 32 | 0.060 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2005 | 18 | 0.060 |
Why?
|
| Hydroxamic Acids | 1 | 2005 | 60 | 0.060 |
Why?
|
| Mice | 3 | 2012 | 18301 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2006 | 116 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2010 | 477 | 0.060 |
Why?
|
| Hypertension | 2 | 2014 | 1356 | 0.060 |
Why?
|
| Elastin | 1 | 2005 | 32 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2006 | 1618 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 1319 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2010 | 791 | 0.060 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2005 | 89 | 0.050 |
Why?
|
| Animals | 5 | 2013 | 33912 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2005 | 160 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2006 | 1363 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 533 | 0.050 |
Why?
|
| Actins | 1 | 2005 | 321 | 0.050 |
Why?
|
| Male | 9 | 2014 | 64957 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 4738 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2006 | 483 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 633 | 0.040 |
Why?
|
| Cell Line | 1 | 2006 | 2552 | 0.040 |
Why?
|
| Time Factors | 2 | 2014 | 6196 | 0.040 |
Why?
|
| Models, Biological | 1 | 2006 | 1371 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2006 | 690 | 0.040 |
Why?
|
| Gene Expression | 3 | 2012 | 1481 | 0.040 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2010 | 33 | 0.040 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2013 | 142 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2006 | 2406 | 0.040 |
Why?
|
| Inflammation | 1 | 2006 | 1489 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2012 | 645 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 2833 | 0.030 |
Why?
|
| Female | 7 | 2014 | 70963 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2012 | 12936 | 0.030 |
Why?
|
| Rats | 2 | 2013 | 3370 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2008 | 686 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 2010 | 451 | 0.030 |
Why?
|
| DNA-Binding Proteins | 3 | 2008 | 1939 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2008 | 556 | 0.030 |
Why?
|
| Citric Acid | 1 | 2014 | 45 | 0.030 |
Why?
|
| Blood Specimen Collection | 1 | 2014 | 46 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 92 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2013 | 53 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2013 | 106 | 0.020 |
Why?
|
| ADAMTS4 Protein | 1 | 2012 | 9 | 0.020 |
Why?
|
| ADAMTS1 Protein | 1 | 2012 | 15 | 0.020 |
Why?
|
| Base Sequence | 2 | 2008 | 2730 | 0.020 |
Why?
|
| Myofibroblasts | 1 | 2013 | 64 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 2121 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 97 | 0.020 |
Why?
|
| Heparin | 1 | 2014 | 208 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 299 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2012 | 112 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2013 | 148 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 3464 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 50 | 0.020 |
Why?
|
| Aortic Rupture | 1 | 2013 | 112 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2013 | 232 | 0.020 |
Why?
|
| Chaperonin 60 | 1 | 2011 | 31 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 325 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2011 | 72 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 826 | 0.020 |
Why?
|
| Acute Disease | 1 | 2014 | 1153 | 0.020 |
Why?
|
| Rats, Inbred SHR | 1 | 2010 | 54 | 0.020 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2011 | 150 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2014 | 605 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2010 | 172 | 0.020 |
Why?
|
| Collagen | 1 | 2010 | 273 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 619 | 0.020 |
Why?
|
| Macrophages | 1 | 2012 | 667 | 0.020 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2008 | 16 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2008 | 18 | 0.020 |
Why?
|
| Acetylation | 1 | 2008 | 190 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2008 | 136 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2008 | 422 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2008 | 394 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2904 | 0.020 |
Why?
|
| Compliance | 1 | 2006 | 17 | 0.020 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2006 | 21 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2006 | 54 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2008 | 307 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2006 | 121 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 88 | 0.010 |
Why?
|
| Luciferases | 1 | 2006 | 127 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2013 | 2465 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 107 | 0.010 |
Why?
|
| Response Elements | 1 | 2006 | 102 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 165 | 0.010 |
Why?
|
| Caspases | 1 | 2006 | 152 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2006 | 293 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 588 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2005 | 341 | 0.010 |
Why?
|
| Biomarkers | 1 | 2014 | 3385 | 0.010 |
Why?
|
| Adult | 3 | 2014 | 31282 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 325 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 4497 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 749 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 776 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2008 | 1077 | 0.010 |
Why?
|
| Smoking | 1 | 2006 | 932 | 0.010 |
Why?
|
| DNA | 1 | 2006 | 1399 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 2595 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1801 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 3436 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 6797 | 0.010 |
Why?
|
| Adolescent | 1 | 2006 | 20987 | 0.000 |
Why?
|